Results 71 to 80 of about 131,203 (163)

Telmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19

Scientific Reports
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a respiratory viral infection that disrupts renin angiotensin system (RAS) peptide metabolism by downregulating angiotensin converting enzyme-II (ACE2), leading to accumulation
Angela Lu, Melissa Agsalda-Garcia, Weiyuan Hu, Catherine Chester, Aditya Anil Naik, Brooks I. Mitchell, Isaac Asante, Scott A. Souza, Kuo-Chiang Lian, Zao Zhang, Hannah V. Schmitz, Malia L. Ramirez, Richa Varshney, Serena DelMundo, Dominic C. Chow, Cecilia M. Shikuma, Stan G. Louie   +16 more
doaj   +1 more source

Expression of Concern: NF-κB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons. [PDF]

PLoS One, 2023
PLOS ONE Editors.
europepmc   +1 more source

Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment. [PDF]

Cureus, 2023
Allison D, Hajjiri Z, Manon L, Campbell-Lee S, Sahni S, Setty S.   +5 more
europepmc   +1 more source

Unraveling allostery within the angiotensin II type 1 receptor for Gα_q and β-arrestin coupling. [PDF]

Sci Signal, 2023
Cao Y, van der Velden WJC, Namkung Y, Nivedha AK, Cho A, Sedki D, Holleran B, Lee N, Leduc R, Muk S, Le K, Bhattacharya S, Vaidehi N, Laporte SA.   +13 more
europepmc   +1 more source

Angiotensin II Type 1 Receptor Antibodies: Great Expectations? [PDF]

American Journal of Transplantation, 2013
K, Tinckam, P, Campbell
openaire   +2 more sources

The Role of Angiotensin II Type 1 Receptor A1166C Polymorphism in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Cureus, 2023
Sasidharan A, Mv B, Mani R, P S.
europepmc   +1 more source

Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients. [PDF]

Pediatr Nephrol, 2023
Stern R, Chen L, Chan AP, Wozniak LJ, Pearl M.   +4 more
europepmc   +1 more source

Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist. [PDF]

Biomedicines, 2023
Matsuo Y, Suematsu Y, Morita H, Miura SI.   +3 more
europepmc   +1 more source

[Retracted] Cocktail therapy with a combination of interferon, ribavirin and angiotensin‑II type 1 receptor blocker attenuates murine liver fibrosis development. [PDF]

Int J Mol Med
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Shirai Y, Yoshii J, Yanase K, Fukui H.   +8 more
europepmc   +1 more source

Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor. [PDF]

J Mol Graph Model, 2023
Nivedha AK, Lee S, Vaidehi N.
europepmc   +1 more source